• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Joyce D. Fingeroth, MD


  • Arredouani MS, Bhasin MK, Sage D, Dunn LK, Gill MB, Agnani D, Libermann TA, Fingeroth J.Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation and initiation of virus infection.J Virol. 2014 Mar 5.
  • Sun X, Bristol JA, Iwahori S, Hagemeier SR, Meng Q, Barlow EA, Fingeroth JD, Tarakanova VL, Kalejta RF, Kenney SC.Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells.J Virol. 2013 Sep;87(18):10126-38.
  • Ogembo JG, Kannan L, Ghiran I, Nicholson-Weller A, Finberg RW, Tsokos GC, Fingeroth JD.Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor.Cell Rep. 2013 Feb 21;3(2):371-85.
  • Meng Q, Hagemeier SR, Fingeroth JD, Gershburg E, Pagano JS, Kenney SC.The EBV-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.J Virol. 2010 May;84(9):4534-42.
  • Perrine SP, Hermine O, Small T, Suarez F, O'Reilly R, Boulad F, Fingeroth J, Askin M, Levy A, Mentzer SJ, Di Nicola M, Gianni AM, Klein C, Horwitz S, Faller DV.A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.Blood. 2007 Mar 15;109(6):2571-8.
  • Gill MB, Murphy JE, Fingeroth JD.Functional Divergence of Kaposi's Sarcoma-Associated Herpesvirus and Related Gamma-2 Herpesvirus Thymidine Kinases: Novel Cytoplasmic Phosphoproteins That Alter Cellular Morphology and Disrupt Adhesion.J Virol. 2005 Dec;79(23):14647-59.
  • Zhang X, Wang JF, Chandran B, Persaud K, Pytowski B, Fingeroth J, Groopman JE.Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection.J Biol Chem. 2005 Jul 15;280(28):26216-24.
  • Hong YK, Foreman K, Shin JW, Hirakawa S, Curry CL, Sage DR, Libermann T, Dezube BJ, Fingeroth JD, Detmar M.Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus.Nat Genet. 2004 Jul;36(7):683-5.
  • Gill MB, Roecklein-Canfield J, Sage DR, Zambela-Soediono M, Longtine N, Uknis M, Fingeroth JD.EBV attachment stimulates FHOS/FHOD1 redistribution and co-aggregation with CD21: formin interactions with the cytoplasmic domain of human CD21.J Cell Sci. 2004 Jun 1;117(Pt 13):2709-20.
  • Paulson EJ, Fingeroth JD, Yates JL, Speck SH.Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells.Virology. 2002 Jul 20;299(1):109-21.
  • Dezube BJ, Zambela M, Sage DR, Wang JF, Fingeroth JD.Characterization of Kaposi sarcoma-associated herpesvirus/human herpesvirus-8 infection of human vascular endothelial cells: early events.Blood. 2002 Aug 1;100(3):888-96.
  • Prota AE, Sage DR, Stehle T, Fingeroth JD.The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding.Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10641-6.
  • Fingeroth JD.Herpesvirus infection of the liver.Infect Dis Clin North Am. 2000 Sep;14(3):689-719.
  • Oram RJ, Marcellino D, Strauss D, Gustafson E, Talarico CL, Root AK, Sharma PL, Thompson K, Fingeroth JD, Crumpacker C, Herold BC.Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate.J Infect Dis. 2000 Apr;181(4):1458-61.
  • Gustafson EA, Schinazi RF, Fingeroth JD.Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir.J Virol. 2000 Jan;74(2):684-92.
  • Marshall WL, Yim C, Gustafson E, Graf T, Sage DR, Hanify K, Williams L, Fingeroth J, Finberg RW.Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak.J Virol. 1999 Jun;73(6):5181-5.
  • Chauhan D, Bharti A, Raje N, Gustafson E, Pinkus GS, Pinkus JL, Teoh G, Hideshima T, Treon SP, Fingeroth JD, Anderson KC.Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells.Blood. 1999 Mar 1;93(5):1482-6.
  • Fingeroth JD, Diamond ME, Sage DR, Hayman J, Yates JL.CD21-Dependent infection of an epithelial cell line, 293, by Epstein-Barr virus.J Virol. 1999 Mar;73(3):2115-25.
  • Gustafson EA, Chillemi AC, Sage DR, Fingeroth JD.The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase.Antimicrob Agents Chemother. 1998 Nov;42(11):2923-31.
  • Sage DR, Chillemi AC, Fingeroth JD.A versatile prokaryotic cloning vector with six dual restriction enzyme sites in the polylinker facilitates efficient subcloning into vectors with unique cloning sites.Plasmid. 1998 Sep;40(2):164-8.
  • Vance EA, Soiffer RJ, McDonald GB, Myerson D, Fingeroth J, Ritz J.Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon.Transplantation. 1996 Nov 15;62(9):1358-60.
  • Kuhn-Hallek I, Sage DR, Stein L, Groelle H, Fingeroth JD.Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells.Blood. 1995 Mar 1;85(5):1289-99.
  • Shuhart MC, Myerson D, Childs BH, Fingeroth JD, Perry JJ, Snyder DS, Spurgeon CL, Bevan CA, McDonald GB.Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course.Blood. 1994 Nov 1;84(9):3229-35.
  • Fingeroth JD, Roth RS, Talcott JA, Rinaldi MG.Zygomycosis due to Mucor circinelloides in a neutropenic patient receiving chemotherapy for acute myelogenous leukemia.Clin Infect Dis. 1994 Jul;19(1):135-7.
  • Barut BA, Zon LI, Cochran MK, Paul SR, Chauhan D, Mohrbacher A, Fingeroth J, Anderson KC.Role of interleukin 6 in the growth of myeloma-derived cell lines.Leuk Res. 1992 Oct;16(10):951-9.
  • Freeman GJ, Gray GS, Gimmi CD, Lombard DB, Zhou LJ, White M, Fingeroth JD, Gribben JG, Nadler LM.Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.J Exp Med. 1991 Sep 1;174(3):625-31.
  • Fingeroth JD.Comparative structure and evolution of murine CR2. The homolog of the human C3d/EBV receptor (CD21).J Immunol. 1990 May 1;144(9):3458-67.
  • Fingeroth JD, Heath ME, Ambrosino DM.Proliferation of resting B cells is modulated by CR2 and CR1.Immunol Lett. 1989 Jun 15;21(4):291-301.
  • Fingeroth JD, Benedict MA, Levy DN, Strominger JL.Identification of murine complement receptor type 2.Proc Natl Acad Sci U S A. 1989 Jan;86(1):242-6.
  • Fingeroth JD, Clabby ML, Strominger JD.Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21).J Virol. 1988 Apr;62(4):1442-7.
  • Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT.Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.Proc Natl Acad Sci U S A. 1984 Jul;81(14):4510-4.